Ataxia With Vitamin E Deficiency is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ataxia with Vitamin E Deficiency (AVED) is a rare autosomal recessive neurodegenerative disorder characterized by progressive cerebellar ataxia, peripheral neuropathy, and significantly reduced serum vitamin E levels. The disease results from mutations in the TTPA gene (alpha-tocopherol transfer protein), which impairs the body's ability to utilize and transport vitamin E.[@syndromic]
Overview
AVED is a hereditary ataxia that mimics Friedreich's ataxia in its clinical presentation but is potentially treatable with vitamin E supplementation. The condition was first described in 1981 and is estimated to affect approximately 1 in 500,000 individuals worldwide, though it may be underdiagnosed due to clinical overlap with other ataxias.[@clinical]
Genetics and Pathophysiology
Gene Mutation
AVED is caused by homozygous or compound heterozygous mutations in the TTPA gene located on chromosome 8q13.1. This gene encodes alpha-tocopherol transfer protein (α-TTP), which is responsible for incorporating alpha-tocopherol (the most active form of vitamin E) into very-low-density lipoprotein (VLDL) for distribution to tissues.[@dietary]
More than 40 pathogenic variants have been identified in TTPA, including:
Nonsense mutations
Missense mutations
Frameshift mutations
Splice site mutations
...
Ataxia with Vitamin E Deficiency
Introduction
Ataxia With Vitamin E Deficiency is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ataxia with Vitamin E Deficiency (AVED) is a rare autosomal recessive neurodegenerative disorder characterized by progressive cerebellar ataxia, peripheral neuropathy, and significantly reduced serum vitamin E levels. The disease results from mutations in the TTPA gene (alpha-tocopherol transfer protein), which impairs the body's ability to utilize and transport vitamin E.[@syndromic]
Overview
AVED is a hereditary ataxia that mimics Friedreich's ataxia in its clinical presentation but is potentially treatable with vitamin E supplementation. The condition was first described in 1981 and is estimated to affect approximately 1 in 500,000 individuals worldwide, though it may be underdiagnosed due to clinical overlap with other ataxias.[@clinical]
Genetics and Pathophysiology
Gene Mutation
AVED is caused by homozygous or compound heterozygous mutations in the TTPA gene located on chromosome 8q13.1. This gene encodes alpha-tocopherol transfer protein (α-TTP), which is responsible for incorporating alpha-tocopherol (the most active form of vitamin E) into very-low-density lipoprotein (VLDL) for distribution to tissues.[@dietary]
More than 40 pathogenic variants have been identified in TTPA, including:
Nonsense mutations
Missense mutations
Frameshift mutations
Splice site mutations
The most common mutation varies by population, with the p.Lys197Asnfs*38 mutation being frequent in North African families.[@ttpa]
Pathophysiology
Vitamin E deficiency in AVED leads to:
Increased oxidative stress - Alpha-tocopherol is a potent antioxidant that protects cell membranes from lipid peroxidation
Neuronal damage - Particularly in cerebellar Purkinje cells and peripheral nerve axons
Myelin degeneration - Demyelination of peripheral nerves and central nervous system pathways
The study of Ataxia With Vitamin E Deficiency has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research (2024-2026)
This section highlights recent publications relevant to this disease.
[Syndromic retinitis pigmentosa.](https://pubmed.ncbi.nlm.nih.gov/39733931/) (2025 Jul) - Progress in retinal and eye research
[Clinical and genetic analysis of a case series of 12 Chinese families with hereditary ataxia.](https://pubmed.ncbi.nlm.nih.gov/40635703/) (2025) - Frontiers in neurology
[Dietary and lifestyle interventions for the management of hereditary ataxias.](https://pubmed.ncbi.nlm.nih.gov/40342369/) (2025) - Frontiers in nutrition
[A TTPA deletion is associated with retinopathy with vitamin E deficiency in the English Cocker Spaniel dog.](https://pubmed.ncbi.nlm.nih.gov/39874248/) (2025 Apr 17) - G3 (Bethesda, Md.)
[Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and In Silico Analysis.](https://pubmed.ncbi.nlm.nih.gov/39702880/) (2025 Mar) - Clinical genetics
[Unknown, Clinical and genetic analysis of a case series of 12 Chinese families with hereditary ataxia (n.d.)](https://pubmed.ncbi.nlm.nih.gov/40635703/)
[Unknown, Dietary and lifestyle interventions for the management of hereditary ataxias (n.d.)](https://pubmed.ncbi.nlm.nih.gov/40342369/)
[Unknown, A TTPA deletion is associated with retinopathy with vitamin E deficiency in the English Cocker Spaniel dog (n.d.)](https://pubmed.ncbi.nlm.nih.gov/39874248/)
[Unknown, Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and In Silico Analysis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/39702880/)